Artikel: Ustekinumab for the treatment of psoriasis: an evidence update.
Seminars in cutaneous medicine and surgery
2018 Band 37, Heft 3, Seite(n) 143–147
Abstract: Ustekinumab is an interleukin-12/23 inhibitor used for the treatment of moderate-to-severe psoriasis. Here, we review new evidence since ustekinumab was licensed for relative efficacy in comparison with other biologic therapies from head-to-head ... ...
Abstract | Ustekinumab is an interleukin-12/23 inhibitor used for the treatment of moderate-to-severe psoriasis. Here, we review new evidence since ustekinumab was licensed for relative efficacy in comparison with other biologic therapies from head-to-head randomized controlled trials and network meta-analyses for the treatment of psoriasis. We also review observational data emerging from psoriasis registries reporting the effectiveness and safety of ustekinumab. Overall, new evidence suggests that ustekinumab has a favorable balance between efficacy/effectiveness, safety, and tolerability and should remain a first-line biologic therapy option for patients with severe psoriasis at present. |
---|---|
Mesh-Begriff(e) | Dermatologic Agents/adverse effects ; Dermatologic Agents/therapeutic use ; Humans ; Infections/chemically induced ; Observational Studies as Topic ; Psoriasis/drug therapy ; Psoriasis/genetics ; Randomized Controlled Trials as Topic ; Ustekinumab/adverse effects ; Ustekinumab/therapeutic use |
Chemische Substanzen | Dermatologic Agents ; Ustekinumab (FU77B4U5Z0) |
Sprache | Englisch |
Erscheinungsdatum | 2018-09-14 |
Erscheinungsland | United States |
Dokumenttyp | Journal Article ; Review |
ZDB-ID | 1355511-x |
ISSN | 1558-0768 ; 1085-5629 |
ISSN (online) | 1558-0768 |
ISSN | 1085-5629 |
DOI | 10.12788/j.sder.2018.040 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 1754: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.